Exp Clin Endocrinol Diabetes 1998; 106: S10-S15
DOI: 10.1055/s-0029-1212049
Molecular Basis of Autonomy

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Autosomal dominant nonautoimmune hyperthyroidism Clinical features - diagnosis - therapy

D. Führer1 , M. Mix3 , H. Willgerodt2 , H. P. Holzapfel1 , W. v. Petrykowski4 , P. Wonerow1 , R. Paschke1
  • 1III. Medical Department, University of Leipzig
  • 2Paediatric Clinic, University of Leipzig
  • 3Paediatric Clinic, University of Rostock
  • 4Children's Hospital, University of Freiburg, Germany
Further Information

Publication History

Publication Date:
14 July 2009 (online)

Abstract

Autosomal dominant nonautoimmune hyperthyroidism is a hereditary form of hyperthyroidism caused by constitutively activating germline mutations in the TSH-receptor gene. Clinical features comprise familial prevalence of thyroid autonomy in more than 2 generations and conditions of persisting neonatal hyperthyroidism or nonautoimmune hyperthyroidism of childhood onset with frequent relapses of hyperthyroidism under thyrostatic therapy and after thyroid surgery. Once clinically suspected the diagnosis can be confirmed by mutation analysis of genomic DNA extracted from a routinely obtainable EDTA blood sample. In patients with hereditary nonautoimmune hyperthyroidism a near total thyroidectomy is recommended as the first line treatment to avoid relapses from residual thyroid tissue with the activating TSHR mutation. Furthermore, genetic counselling of the affected patients is advised.